A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Clinical trial NCT03073525 · COMPLETED
Trial details
- NCT number
- NCT03073525
- Sponsor
- Gradalis, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2019-05-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.